Covidien wraps spinoff of drug unit

Covidien ($COV) has completed the spinoff of its pharma unit, Mallinckrodt. Mallinckrodt has a small pipeline of novel and generic drugs as well as imaging agents. It is trading on the New York Stock Exchange under the symbol MNK. Report

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.